Sort
326,823 grants matching “clinical trial”
STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH ON INFECTIOUS DISEASES
$15,346,253Marian Ewell · The Emmes Company, Llc · N01 · FY2020 · AI
CHILDRENS CANCER GROUP CHAIRMANS AWARD
$15,287,240National Childhood Cancer Foundation · U10 · FY2002 · CA
Alzheimer's Prevention Initiative
$15,252,950Eric M Reiman · Banner Alzheimer'S Institute · RF1 · FY2012 · AG
NIAID/Division of AIDS: Regulatory Support Center
$15,247,125Asimah Rafi · Technical Resources International, Inc. · N01 · FY2021 · AI
Statistical and Data Coordinating Center
$15,186,116Marian Ewell · The Emmes Company, Llc · N01 · FY2021 · AI
University of Pittsburgh Clinical and Translational Science Institute
$15,166,493Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2020 · TR
COG NCTN Network Group Operations Center Year 11 Extension
$15,151,031Douglas S. Hawkins · Public Health Institute · U10 · FY2025 · CA
Vaccination for Recovered Inpatients with COVID-19 (VATICO)
$15,147,252Laura McNay · Leidos Biomedical Research, Inc. · N01 · FY2021 · AI
NHGRI/DIR Clinical Support Services
$15,142,818William Gahl · National Human Genome Research Institute · ZID · FY2013 · HG
NIAID/DIVISION OF AIDS:CLINICAL SITE AND STUDY MONITORING
$15,127,582Michelle Vargas · Ppd Development Lp · N01 · FY2015 · AI
DCTD Drug Development Project Management
$15,125,111David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Development/production of universal influenza vaccines
$15,099,170Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2015 · AI
UCLA Clinical and Translational Science Institute
$15,079,371Steven M. Dubinett · University Of California Los Angeles · UL1 · FY2012 · TR
Therapeutics/Vaccine Teams
$15,067,360Charles Nicolette · Argos Therapeutics, Inc. · N01 · FY2010 · AI
Statistical and Data Management Center for the AIDS Clinical Trials Group
$15,061,511Michael David Hughes · Harvard School Of Public Health · UM1 · FY2012 · AI
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES FOLLOW-ON (ACCORDION) STUDY- C
$15,053,808Robert Byington · Wake Forest University Health Sciences · N01 · FY2011 · HL
Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines
$15,048,720Kiran Datta · Leidos Biomedical Research, Inc. · N01 · FY2024 · AI
Access for All in ALS (ALL ALS) East Clinical Coordinating Center
$15,032,251James Dale Berry · Massachusetts General Hospital · OT2 · FY2024 · NS
DCTD Drug Development Project Management
$15,014,872David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Revision to the Coordinating Center for Type 1 Diabetes TrialNet
$15,000,000Jeffrey P Krischer · University Of South Florida · U01 · FY2022 · DK
Space Renovation for New Research Center for the Neglected Diseases of Poverty
$15,000,000Jeffrey S Akman · George Washington University · C06 · FY2010 · RR
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
$15,000,000Susan Abushakra · Alzheon, Inc. · R01 · FY2020 · AG
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$14,994,115Michael David Hughes · Harvard School Of Public Health · UM1 · FY2020 · AI
ProCAN: Psychosis Risk Outcomes Compound Assessment Network
$14,993,866Scott W Woods · Yale University · U01 · FY2024 · MH
Development/production of universal influenza vaccines
$14,987,979Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2020 · AI